Bloomios Inc
OTC:BLMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bloomios Inc
Change in Working Capital
Bloomios Inc
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bloomios Inc
OTC:BLMS
|
Change in Working Capital
$2.1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Change in Working Capital
-$436m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Change in Working Capital
$50m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Balchem Corp
NASDAQ:BCPC
|
Change in Working Capital
-$7.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-54%
|
|
|
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
Change in Working Capital
-$1m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-11%
|
|
|
T
|
Trulieve Cannabis Corp
CNSX:TRUL
|
Change in Working Capital
$193.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bloomios Inc
Glance View
Bloomios, Inc. is a blank check company, which engages in pursuing potential new business opportunity by way of a merger and acquisition with an unidentified company, an acquisition of assets, and other form of business combination. The company is headquartered in Santa Barbara, California. The company went IPO on 2003-10-14. The firm is engaged in the growing, processing, extraction, and manufacture of cannabidiol (CBD) products. The firm sells its products to business to business (B2B) customers.
See Also
What is Bloomios Inc's Change in Working Capital?
Change in Working Capital
2.1m
USD
Based on the financial report for Dec 31, 2022, Bloomios Inc's Change in Working Capital amounts to 2.1m USD.
What is Bloomios Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
69%
Over the last year, the Change in Working Capital growth was 425%. The average annual Change in Working Capital growth rates for Bloomios Inc have been 69% over the past three years .